【环球网财经综合报道】2026年伊始，公募基金发行市场便上演"速度与激情"。据Wind数据统计，截 至1月5日，已有71只新基金定档1月发行，其中仅元旦假期后的首个交易周（1月5日至1月9日），便有 44只新产品扎堆发售，以"抢跑"姿态开启了新一年的市场角逐。 从产品布局来看，权益类产品无疑占据了C位。在1月新发基金中，主动偏股型基金占比近30%，股票型 基金占比约35%，两者合计占据了发行市场的半壁江山。值得关注的是，基金公司的发行策略紧密贴合 产业趋势，超过30%的新发基金明确锚定科技、医疗、科创板等特定赛道，科技主题投资更是成为各大 机构的"必争之地"。 科技主题成 " 绝对核心 " ， AI 与机器人受热捧 在具体的投资方向上，科技成长为了2026年开年最耀眼的明星。在已定档的1月新基中，约36%的产品 为行业或主题型基金，重点布局科技、电池、工业软件、信息技术等领域。 具体来看，平安基金、前海开源基金均将推出港股通科技主题ETF；南方基金、大成基金则瞄准了中证 电池主题ETF；万家基金也计划发售新能源车电池ETF。主动权益方面，汇添富、工银瑞信、上银等基 金公司也纷纷布局科技主题基金。 机构普遍认为 ...

新年伊始，公募基金发行角逐一触即发。据Wind统计，目前，已有71只新基金定档2026年1月发行（以 认购起始日为准，下同）。其中，仅2026年1月5日~1月9日，即元旦假期后的首个交易周，将有44只新 基金扎堆发售。 从产品结构看，权益类产品仍然是基金公司新年首月布局的重头戏。目前来看，在1月的新发基金中， 主动偏股型基金占比接近30%，而股票型基金（以增强指数、被动指数基金为主）的占比约为35%。 同时，基金公司的发行策略呈现出与产业趋势紧密对齐的态势：超过30%的新发基金明确指向特定行业 或主题，如科技、医疗、科创板等。 扎堆发行为哪般？ 2026年开年，公募基金产品"上新"节奏颇有提速之势。 Wind数据显示，2026年首个交易日——1月5日，共有28只新基金集中发售；包括这28只产品在内，于 2026年1月5日~1月9日发行的新基金共计44只。另有27只新基金将在2026年1月12日~1月28日陆续发 售。 这番热闹景象是多种因素共同作用的结果。 "一方面，年初渠道资源较为充足，投资者资金有可能逐步回流，有助于基金快速募集，抢占市场份 额。另一方面，市场普遍对A股'春季躁动'抱有预期，年初估值处于相 ...

21世纪经济报道记者 易妍君 新年伊始，公募基金发行角逐一触即发。据Wind统计，目前，已有71只新基金定档2026年1月发行（以认购起始日为准，下同）。其中，仅 2026年1月5日~1月9日，即元旦假期后的首个交易周，将有44只新基金扎堆发售。 从产品结构看，权益类产品仍然是基金公司新年首月布局的重头戏。目前来看，在1月的新发基金中，主动偏股型基金占比接近30%，而股票 型基金（以增强指数、被动指数基金为主）的占比约为35%。 从产品类型看，上述计划于2026年1月发行的71只新基金中，股票型基金的占比较高，约为35%；其次是混合型基金，占比约为34%；新发债 券型基金、FOF的占比均为14%，另外还包括2只QDII基金。 若进一步细分，指数型基金、主动偏股型基金的占比较高，反映出基金公司"卡位"权益市场热情较高。 曾方芳表示，整体上，1月新发基金呈现出"权益为主、工具化突出、多元补充"的配置特征。权益类产品占比较高，既包括主动混合型基金， 也涵盖各类指数基金，其中指数产品多聚焦于科创板、港股通互联网等特定赛道，契合市场对工具化投资需求上升的趋势。 同时，基金公司的发行策略呈现出与产业趋势紧密对齐的态势：超 ...

Core Insights - The recovery of market conditions and increased capital activity have led to a significant positive performance of equity funds, with over 97% achieving positive returns this year, and 81 funds doubling their performance [1][6][7] - Institutional investors are heavily investing in the CSI 300 ETF, while fund management companies are increasing their investments in their own pension funds, indicating confidence in long-term strategies [1][6][7] Institutional Investor Holdings - As of mid-2025, the top 20 equity funds held by institutional investors are predominantly ETFs, with a strong focus on broad-based ETFs like the CSI 300 ETF [3][4] - The top four funds held by institutions are all tracking the CSI 300 index, with the Huatai-PB CSI 300 ETF leading with over 300 billion yuan in holdings [6][7] - Institutional investors are showing a preference for funds with high liquidity and broad market coverage, particularly in the context of the recent market recovery [7][8] Fund Management Company Holdings - Fund management companies are significantly investing in their own pension funds, with several pension FOFs appearing in the top holdings [18][19] - The top fund held by management companies is the Huatai-PB MSCI China A50 ETF, which has shown strong performance with a 22.51% increase this year [21][23] Employee Holdings - Employees of fund management companies exhibit diverse investment preferences, with a mix of value and growth strategies being favored [34] - Certain funds are exclusively available to institutional investors, resulting in 100% holdings by fund management companies for specific products [11][26] Changes in Holdings - There has been a notable increase in holdings for the CSI 300 ETFs and other technology-focused ETFs, reflecting a trend towards sectors with high growth potential [12][13] - Conversely, some funds have experienced significant redemptions, particularly those with a conservative investment strategy [31][32]

Core Insights - The article highlights the significant performance of equity funds in 2023, with over 97% achieving positive returns and 81 funds doubling their performance [1][6] - Institutional investors are heavily investing in the CSI 300 ETF and increasing their positions in Hong Kong Stock Connect technology-themed ETFs [1][8] - Fund management companies are showing confidence in long-term investments by increasing their holdings in their own pension funds [1][20] Group 1: Institutional Investor Holdings - Institutional investors are primarily holding ETFs, with the top 20 equity funds being ETF products, predominantly broad-based ETFs [4][7] - The top four funds held by institutions are all tracking the CSI 300 index, with the Huatai-PB CSI 300 ETF leading with over 300 billion yuan in holdings [7][8] - The appeal of the CSI 300 ETF to institutional investors is attributed to its large scale, liquidity, and the ability to quickly build positions [8] Group 2: Fund Management Company Holdings - Fund management companies are significantly investing in their own pension funds, with several pension FOFs ranking among the top holdings [20][24] - The highest amount of self-investment is seen in the Huatai-PB MSCI China A50 ETF, which has a year-to-date return of 22.51% [23][24] - Many pension FOFs held by fund management companies have shown impressive performance, with some exceeding benchmark returns by substantial margins [24][26] Group 3: Employee Holdings - Fund company employees are diversifying their investments across various products, with a mix of value and growth strategies [36][37] - The top holdings among employees include funds like Zhonggeng Value Pioneer and E Fund Advantage Leading, reflecting varied investment styles [36][37] - Employee investments indicate a strong belief in the potential of their own funds, with significant amounts allocated to high-performing products [36][37]

Core Insights - The recovery of market conditions and increased capital activity have led to significant profitability in equity funds, with over 97% achieving positive returns this year, and 81 funds doubling their performance [1] - Institutional investors are heavily investing in the CSI 300 ETF, while fund management companies are increasing their allocations to their own pension funds, indicating confidence in long-term strategies [2][4] Institutional Investor Holdings - As of mid-2025, institutional investors are primarily holding broad-based ETFs, with the top four funds tracking the CSI 300 index, each having over 160 billion yuan in holdings [4] - The central government-backed Central Huijin is a major buyer of CSI 300 ETFs, holding over 70% of the shares in the top funds [4][5] - The appeal of the CSI 300 ETF lies in its liquidity and broad coverage of large-cap stocks, making it suitable for large capital inflows [5] Fund Management Company Holdings - Fund management companies are significantly investing in their own pension funds, with several funds like E Fund's pension fund receiving substantial internal support [10] - The highest internal investment is in the E Fund MSCI China A50 ETF, which has seen a year-to-date return of 22.51%, outperforming its benchmark [10] Employee Holdings - Employees of fund management companies show diverse preferences in fund styles, with significant holdings in both value and growth strategies [15] - The top employee-held fund is Zhonggeng Value Pioneer, with a total holding of 191 million yuan, although it has underperformed its benchmark [15][16] - Employee holdings are concentrated in smaller funds, with a notable preference for balanced and growth-oriented strategies [17] Changes in Holdings - There has been a notable increase in employee holdings of ETF-linked funds, reflecting a trend towards lower investment thresholds and easier access for individual investors [19] - The most increased fund among employees is Xingquan Helun C, which focuses on materials and technology sectors, indicating a preference for high-quality assets [19][20]

Group 1 - The core viewpoint of the article highlights the significant performance disparity between actively managed equity funds and thematic ETFs, particularly in the context of the booming human-robot and innovative drug sectors [1][2][4] - The number of "doubling funds" in the innovative drug sector reached 17 by July 29, with 10 being actively managed equity funds and 7 being thematic ETFs, showcasing the strong performance of these funds [2][3] - Actively managed equity funds have achieved substantial excess returns due to stock-picking abilities, but their scale expansion has lagged behind that of ETFs, which have benefited from the strong market performance of specific sectors [2][3] Group 2 - Data shows that the 10 actively managed innovative drug funds had a total scale of 9.4 billion yuan at the end of Q2, with an increase of 5.8 billion yuan during the quarter, while the 7 ETFs saw an increase of 12.9 billion yuan, reaching 28.4 billion yuan [3] - The rapid growth of ETFs is attributed to their passive tracking mechanism, which allows them to capture industry beta returns effectively, leading investors to prefer ETFs for quick exposure to high-growth sectors [4][5] - The rise of ETFs has created competitive pressure on actively managed equity funds, which are struggling to attract new investments despite their strong performance [5][6] Group 3 - The article notes that the existence of actively managed equity funds remains valuable, as they can smooth out volatility through strategic stock selection, contrasting with the automatic rebalancing of ETFs [6][7] - The current trend indicates that passive products like ETFs are more attractive to investors, prompting actively managed funds to seek differentiated strategies for survival [7] - The article warns that while ETFs offer convenience, investors should be cautious of their short-term speculative nature, which can exacerbate market volatility [8]